{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:09:28Z","timestamp":1784070568211,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08282-z","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:34:18Z","timestamp":1779251658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interferon-induced protein 44-like promoter Hypomethylation as an epigenetic hallmark of systemic lupus erythematosus"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaohui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7219-9141","authenticated-orcid":false,"given":"Zhuoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"17","key":"8282_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480\u201391. https:\/\/doi.org\/10.1001\/jama.2024.2315.","journal-title":"JAMA"},{"issue":"3","key":"8282_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheumatic Dis. 2023;82(3):351\u201356. https:\/\/doi.org\/10.1136\/ard-2022-223035.","journal-title":"Ann Rheumatic Dis"},{"issue":"1","key":"8282_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2478\/rir-2022-0006","volume":"3","author":"X Tian","year":"2022","unstructured":"Tian X, Li M, Wang Q, Zhao J, Zeng X. The challenges and future perspective for the management of systemic lupus erythematosus in China: a concise annual report of 2020. Rheumatol Immunol Res. 2022;3(1):38\u201344. https:\/\/doi.org\/10.2478\/rir-2022-0006.","journal-title":"Rheumatol Immunol Res"},{"issue":"3","key":"8282_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/08916934.2020.1722108","volume":"53","author":"C Hurtado","year":"2020","unstructured":"Hurtado C, Acevedo Saenz LY, Vasquez Trespalacios EM, Urrego R, Jenks S, Sanz I, et al. DNA methylation changes on immune cells in systemic lupus erythematosus. Autoimmunity. 2020;53(3):114\u201321. https:\/\/doi.org\/10.1080\/08916934.2020.1722108.","journal-title":"Autoimmunity"},{"issue":"5","key":"8282_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2017-212379","volume":"77","author":"J Imgenberg-Kreuz","year":"2018","unstructured":"Imgenberg-Kreuz J, Carlsson Almlof J, Leonard D, Alexsson A, Nordmark G, Eloranta ML, et al. DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus. Ann Rheumatic Dis. 2018;77(5):736\u201343. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212379.","journal-title":"Ann Rheumatic Dis"},{"issue":"2","key":"8282_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/ijms25021019","volume":"25","author":"Y Araki","year":"2024","unstructured":"Araki Y, Mimura T. Epigenetic dysregulation in the pathogenesis of systemic lupus erythematosus. IJMS. 2024;25(2):1019. https:\/\/doi.org\/10.3390\/ijms25021019.","journal-title":"IJMS"},{"issue":"8","key":"8282_CR7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheumatic Dis. 2023;82(8):999\u20131014. https:\/\/doi.org\/10.1136\/ard-2022-223741.","journal-title":"Ann Rheumatic Dis"},{"issue":"12","key":"8282_CR8","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow MK. Type I interferon in the pathogenesis of lupus. J Immunol. 2014;192(12):5459\u201368. https:\/\/doi.org\/10.4049\/jimmunol.1002795.","journal-title":"J Immunol"},{"key":"8282_CR9","doi-asserted-by":"publisher","first-page":"155633","DOI":"10.1016\/j.cyto.2021.155633","volume":"146","author":"S Gallucci","year":"2021","unstructured":"Gallucci S, Meka S, Gamero AM. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity. Cytokine. 2021;146:155633. https:\/\/doi.org\/10.1016\/j.cyto.2021.155633.","journal-title":"Cytokine"},{"key":"8282_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jaut.2018.09.007","volume":"96","author":"S Joseph","year":"2019","unstructured":"Joseph S, George NI, Green-Knox B, Treadwell EL, Word B, Yim S, et al. Epigenome-wide association study of peripheral blood mononuclear cells in systemic lupus erythematosus: identifying DNA methylation signatures associated with interferon-related genes based on ethnicity and SLEDAI. J autoimmunity. 2019;96:147\u201357. https:\/\/doi.org\/10.1016\/j.jaut.2018.09.007.","journal-title":"J autoimmunity"},{"issue":"11","key":"8282_CR11","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1136\/annrheumdis-2015-208410","volume":"75","author":"M Zhao","year":"2016","unstructured":"Zhao M, Zhou Y, Zhu B, Wan M, Jiang T, Tan Q, et al. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann Rheumatic Dis. 2016;75(11):1998\u20132006. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208410.","journal-title":"Ann Rheumatic Dis"},{"issue":"1","key":"8282_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.55563\/clinexprheumatol\/q3aa6s","volume":"41","author":"Y Wang","year":"2023","unstructured":"Wang Y, Jia W, Ma Q, Li F, Ma Z, Yang M, et al. Identification of IFI44L as a new candidate molecular marker for systemic lupus erythematosus. Clin Exp Rheumatol. 2023;41(1):48\u201359. https:\/\/doi.org\/10.55563\/clinexprheumatol\/q3aa6s.","journal-title":"Clin Exp Rheumatol"},{"key":"8282_CR13","doi-asserted-by":"publisher","first-page":"108612","DOI":"10.1016\/j.clim.2020.108612","volume":"221","author":"B Zhang","year":"2020","unstructured":"Zhang B, Liu L, Zhou T, Shi X, Wu H, Xiang Z, et al. A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus. Clin Immunol. 2020;221:108612. https:\/\/doi.org\/10.1016\/j.clim.2020.108612.","journal-title":"Clin Immunol"},{"issue":"1","key":"8282_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/jrms.JRMS_83_19","volume":"24","author":"M Karimifar","year":"2019","unstructured":"Karimifar M, Pakzad B, Karimzadeh H, Mousavi M, Kazemi M, Salehi A, et al. Interferon-induced protein 44-like gene promoter is differentially methylated in peripheral blood mononuclear cells of systemic lupus erythematosus patients. J Res Med Sci. 2019;24(1):99. https:\/\/doi.org\/10.4103\/jrms.JRMS_83_19.","journal-title":"J Res Med Sci"},{"issue":"2","key":"8282_CR15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41390-024-03135-1","volume":"96","author":"J Wang","year":"2024","unstructured":"Wang J, Dang X, Wu X, Xiang Z, Li Y, Fu Y, et al. DNA methylation of IFI44L as a potential blood biomarker for childhood-onset systemic lupus erythematosus. Pediatr Res. 2024;96(2):494\u2013501. https:\/\/doi.org\/10.1038\/s41390-024-03135-1.","journal-title":"Pediatr Res"},{"issue":"5546","key":"8282_CR16","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1126\/science.1064890","volume":"294","author":"P Blanco","year":"2001","unstructured":"Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-\u03b1 in systemic lupus erythematosus. Science. 2001;294(5546):1540\u201343. https:\/\/doi.org\/10.1126\/science.1064890.","journal-title":"Science"},{"issue":"11","key":"8282_CR17","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.4049\/jimmunol.0900526","volume":"184","author":"L Pace","year":"2010","unstructured":"Pace L, Vitale S, Dettori B, Palombi C, La Sorsa V, Belardelli F, et al. APC activation by IFN-\u03b1 decreases regulatory T cell and enhances Th cell functions. J Immunol. 2010;184(11):5969\u201379. https:\/\/doi.org\/10.4049\/jimmunol.0900526.","journal-title":"J Immunol"},{"key":"8282_CR18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.intimp.2016.10.012","volume":"40","author":"S Luo","year":"2016","unstructured":"Luo S, Wang Y, Zhao M, Lu Q. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus. Int Immunopharmacol. 2016;40:542\u201349. https:\/\/doi.org\/10.1016\/j.intimp.2016.10.012.","journal-title":"Int Immunopharmacol"},{"key":"8282_CR19","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.jtauto.2021.100092","volume":"4","author":"B Zhang","year":"2021","unstructured":"Zhang B, Zhou T, Wu H, Zhao M, Lu Q. Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals. J Transl Autoimmun. 2021;4:100092. https:\/\/doi.org\/10.1016\/j.jtauto.2021.100092.","journal-title":"J. Transl. Autoimmun"},{"issue":"4","key":"8282_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2217\/epi-2016-0096","volume":"9","author":"CM Hedrich","year":"2017","unstructured":"Hedrich CM, Mabert K, Rauen T, Tsokos GC. DNA methylation in systemic lupus erythematosus. Epigenomics. 2017;9(4):505\u201325. https:\/\/doi.org\/10.2217\/epi-2016-0096.","journal-title":"Epigenomics"},{"issue":"10","key":"8282_CR21","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1136\/annrheumdis-2018-213386","volume":"77","author":"MY Md Yusof","year":"2018","unstructured":"Md Yusof MY, Psarras A, El-Sherbiny YM, Hensor EMA, Dutton K, S S, et al. Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Ann Rheumatic Dis. 2018;77(10):1432\u201338. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213386.","journal-title":"Ann Rheumatic Dis"},{"issue":"11","key":"8282_CR22","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","volume":"75","author":"ME Munroe","year":"2016","unstructured":"Munroe ME, Lu R, Zhao YD, Fife DA, Robertson JM, Guthridge JM, et al. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. Ann Rheumatic Dis. 2016;75(11):2014\u201321. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208140.","journal-title":"Ann Rheumatic Dis"},{"issue":"7","key":"8282_CR23","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/0961203314523869","volume":"23","author":"C Eriksson","year":"2014","unstructured":"Eriksson C, Rantapaa-Dahlqvist S. Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus. Lupus. 2014;23(7):691\u201396. https:\/\/doi.org\/10.1177\/0961203314523869.","journal-title":"Lupus"},{"issue":"3","key":"8282_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2249.2009.04057.x","volume":"159","author":"QZ Li","year":"2010","unstructured":"Li QZ, Zhou J, Lian Y, Zhang B, Branch VK, Carr-Johnson F, et al. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol. 2010;159(3):281\u201391. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.04057.x.","journal-title":"Clin. Exp. Immunol"},{"issue":"4","key":"8282_CR25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3899\/jrheum.210391","volume":"49","author":"T Iwamoto","year":"2022","unstructured":"Iwamoto T, Dorschner JM, Selvaraj S, Mezzano V, Jensen MA, Vsetecka D, et al. High systemic type I interferon activity is associated with active class III\/IV lupus nephritis. J Rheumatol. 2022;49(4):388\u201397. https:\/\/doi.org\/10.3899\/jrheum.210391.","journal-title":"J Rheumatol"},{"issue":"2","key":"8282_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0377-1237(10)80118-2","volume":"66","author":"K Narayanan","year":"2010","unstructured":"Narayanan K, Marwaha V, Shanmuganandan K, Shankar S. Correlation between systemic lupus erythematosus disease activity index, C3, C4 and anti-dsDNA antibodies. Med J Armed Forces India. 2010;66(2):102\u201307. https:\/\/doi.org\/10.1016\/S0377-1237(10)80118-2.","journal-title":"Med J Armed Forces India"},{"issue":"1","key":"8282_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0961203310379871","volume":"20","author":"A Matrat","year":"2011","unstructured":"Matrat A, Veysseyre-Balter C, Trolliet P, Villar E, Dijoud F, Bienvenu J, et al. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Lupus. 2011;20(1):28\u201334. https:\/\/doi.org\/10.1177\/0961203310379871.","journal-title":"Lupus"},{"issue":"8","key":"8282_CR28","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1002\/art.20364","volume":"50","author":"CC Mok","year":"2004","unstructured":"Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, et al. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. Arthritis Rheumatism. 2004;50(8):2559\u201368. https:\/\/doi.org\/10.1002\/art.20364.","journal-title":"Arthritis Rheumatism"},{"issue":"6","key":"8282_CR29","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.4103\/1319-2442.220863","volume":"28","author":"M Hajji","year":"2017","unstructured":"Hajji M, Harzallah A, Kaaroud H, Barbouch S, Hamida FB, Abdallah TB. Factors associated with relapse of lupus nephritis: a single center study of 249 cases. Saudi J Kidney Dis Transplant. 2017;28(6):1349\u201355. https:\/\/doi.org\/10.4103\/1319-2442.220863.","journal-title":"Saudi J Kidney Dis Transplant"},{"issue":"1","key":"8282_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13075-017-1442-6","volume":"19","author":"N Gensous","year":"2017","unstructured":"Gensous N, Marti A, Barnetche T, Blanco P, Lazaro E, Seneschal J, et al. Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review. Arthritis Res Ther. 2017;19(1):238. https:\/\/doi.org\/10.1186\/s13075-017-1442-6.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8282_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.42983","volume":"77","author":"GA Hile","year":"2025","unstructured":"Hile GA, Werth VP. Understanding the role of type I interferons in cutaneous lupus and Dermatomyositis: toward better therapeutics. Arthritis Rheumatol. 2025;77(1):1\u201311. https:\/\/doi.org\/10.1002\/art.42983.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"8282_CR32","doi-asserted-by":"publisher","first-page":"e12955","DOI":"10.1111\/bpa.12955","volume":"31","author":"L Bolko","year":"2021","unstructured":"Bolko L, Jiang W, Tawara N, Landon-Cardinal O, Anquetil C, Benveniste O, et al. The role of interferons type I, II and III in myositis: a review. Brain Pathol. 2021;31(3):e12955. https:\/\/doi.org\/10.1111\/bpa.12955.","journal-title":"Brain Pathol"},{"issue":"3","key":"8282_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11926-011-0166-x","volume":"13","author":"L Kao","year":"2011","unstructured":"Kao L, Chung L, Fiorentino DF. Pathogenesis of dermatomyositis: role of cytokines and interferon. Curr Rheumatol Rep. 2011;13(3):225\u201332. https:\/\/doi.org\/10.1007\/s11926-011-0166-x.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"8282_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/ar3531","volume":"13","author":"EC Baechler","year":"2011","unstructured":"Baechler EC, Bilgic H, Reed AM. Type I interferon pathway in adult and juvenile dermatomyositis. Arthritis Res Ther. 2011;13(6):249. https:\/\/doi.org\/10.1186\/ar3531.","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 1","key":"8282_CR35","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar2885","volume":"12","author":"SA Greenberg","year":"2010","unstructured":"Greenberg SA. Type 1 interferons and myositis. Arthritis Res Ther. 2010;122 Suppl 1: Suppl 1:S4. https:\/\/doi.org\/10.1186\/ar2885.","journal-title":"Arthritis Res Ther"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08282-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08282-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08282-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:03:14Z","timestamp":1784070194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08282-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8282"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08282-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8818542\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Peking University First Hospital (Approval No. 2021\u2013048). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants before enrollment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"905"}}